Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
May 26, 2021
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951
N Sirvent, S Suciu, B De Moerloose, et al.
Annals of Hematology
|
June 9, 2016
Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases
K Mellgren, A Attarbaschi, O Abla, et al.
Human Reproduction (Oxford, England)
|
May 25, 2024
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone
K C E Drechsel, S L Broer, F S Stoutjesdijk, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
Human Reproduction (Oxford, England)
|
September 11, 2024
Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol
K C E Drechsel, S L Broer, H M K van Breda, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Leukemia
|
June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951
E Clappier, N Grardel, M Bakkus, et al.
Nature Genetics
|
September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
C Graux, J Cools, C Melotte, et al.
Leukemia
|
February 24, 2001
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group
E Vilmer, S Suciu, A Ferster, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
May 26, 2021
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951
N Sirvent, S Suciu, B De Moerloose, et al.
Annals of Hematology
|
June 9, 2016
Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases
K Mellgren, A Attarbaschi, O Abla, et al.
Human Reproduction (Oxford, England)
|
May 25, 2024
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone
K C E Drechsel, S L Broer, F S Stoutjesdijk, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
Human Reproduction (Oxford, England)
|
September 11, 2024
Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol
K C E Drechsel, S L Broer, H M K van Breda, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Leukemia
|
June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951
E Clappier, N Grardel, M Bakkus, et al.
Nature Genetics
|
September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
C Graux, J Cools, C Melotte, et al.
Leukemia
|
February 24, 2001
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group
E Vilmer, S Suciu, A Ferster, et al.
Page
of 3